T. Ronan Kennedy - 06 May 2025 Form 4 Insider Report for cbdMD, Inc. (YCBD)

Role
CEO and CFO, Director
Signature
/s/ T. Ronan Kennedy
Issuer symbol
YCBD
Transactions as of
06 May 2025
Net transactions value
$0
Form type
4
Filing time
08 May 2025, 16:13:33 UTC
Previous filing
30 Sep 2024
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kennedy Thomas Ronan CEO and CFO, Director 2101 WESTINGHOUSE BLVD. SUITE A, CHARLOTTE /s/ T. Ronan Kennedy 08 May 2025 0001826452

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YCBD Common Stock Conversion of derivative security +67,869 +1023% 74,501 06 May 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YCBD 8% Series A Cumulative Convertible Preferred Stock Conversion of derivative security -41,765 -100% 0 06 May 2025 Common Stock 67,869 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time.
F2 The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time.
F3 Open market purchases.